Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Anebulo Pharmaceuticals, Inc. (ANEB) had Weighted-Average Shares Outstanding (Diluted) of 25.82M for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-8.20M |
|
-- |
|
-- |
|
$8.31M |
|
$-8.31M |
|
$0.11M |
|
$-8.20M |
|
$-8.20M |
|
$-8.20M |
|
$-8.20M |
|
$-8.20M |
|
$-8.20M |
|
$-8.31M |
|
$-8.16M |
|
25.82M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
25.82M |
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$3.51M |
|
-- |
|
$0.57M |
|
$4.07M |
|
$0.26M |
|
-- |
|
-- |
|
$0.26M |
|
$3.81M |
|
$3.81M |
|
$3.81M |
|
25.93M |
|
| Cash Flow Statement Financials | |
$-8.09M |
|
-- |
|
$-0.06M |
|
$11.25M |
|
$3.09M |
|
$-8.15M |
|
$0.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-215.13% |
|
-215.12% |
|
-201.36% |
|
-215.12% |
|
$0.15 |
|
$-0.31 |
|
$-0.31 |
|